Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515281 · ClinicalTrials.gov registry record · Phase 2
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
A Phase 2 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 2
- Development phase
- 273
- Enrollment target
NCT00515281: Clinical Trial Phase 2 study, sponsored by University of Chicago.
NCT00515281 is a Phase 2 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 273 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (105% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00515281, a Phase 2 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 273 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.
Interventions
- DRUG inhaled nitric oxide
- DRUG oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2008-05 |
| Est. Completion | 2023-11-28 |
| Phase | Phase 2 |
Why NCT00515281 stopped before completion
NCT00515281 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (105% higher).
The record links to 0 conditions, and to 2 interventions - of which inhaled nitric oxide is the first listed.
NCT00515281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00515281 about?
NCT00515281 is a clinical study titled "Inhaled Nitric Oxide and Neuroprotection in Premature Infants". The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.
What is the current status of trial NCT00515281?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 273 participants. The study started on 2008-05. Estimated completion is 2023-11-28.
What interventions are being tested in trial NCT00515281?
The interventions under investigation include: inhaled nitric oxide (DRUG), oxygen (DRUG).
Who is sponsoring clinical trial NCT00515281?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00515281's enrollment target sits among peer trials
273 204th of 2000 higher than 1,797 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia